Table 1 Participants and type of infections
Total undergoing RDT testing | HCV Ab + | HBsAg + | HIV + | HCV Ab + & HBsAg + | HCV Ab + & HIV + | HBsAg + & HIV + | HCV Ab + , HBsAg + , HIV + | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | n | N | %* | n | %* | n | %* | n | %* | n | %* | n | %* | n | %* |
18–19 | 30 | 15 | 50.0 | 0 | 0.0 | 0 | 0.0 | 2 | 6.7 | 0 | 0.0 | 1 | 3.3 | 0 | 0.0 |
20–24 | 148 | 74 | 50.0 | 4 | 2.7 | 0 | 0.0 | 6 | 4.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
25–29 | 159 | 83 | 52.2 | 2 | 1.3 | 0 | 0.0 | 3 | 1.9 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 |
30–34 | 69 | 20 | 29.0 | 1 | 1.4 | 0 | 0.0 | 2 | 2.9 | 0 | 0.0 | 0 | 0.0 | 1 | 1.4 |
35–39 | 40 | 16 | 40.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
40–44 | 33 | 7 | 21.2 | 1 | 3.0 | 0 | 0.0 | 1 | 3.0 | 1 | 3.0 | 0 | 0.0 | 1 | 3.0 |
45–49 | 16 | 5 | 31.3 | 1 | 6.3 | 2 | 12.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
50–54 | 6 | 1 | 16.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 16.7 | 0 | 0.0 | 0 | 0.0 |
55–60 | 2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Total | 503 | 221 | 43.9 | 9 | 1.8 | 2 | 0.4 | 15 | 3.0 | 3 | 0.6 | 1 | 0.2 | 2 | 0.4 |